• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Ingevity Corporation

    3/17/26 4:26:43 PM ET
    $NGVT
    Major Chemicals
    Industrials
    Get the next $NGVT alert in real time by email
    DEFA14A 1 tmb-20260316xdefa14a.htm DEFA14A

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    ​

    SCHEDULE 14A

    ​

    Proxy Statement Pursuant to Section 14(a) of

    the Securities Exchange Act of 1934 (Amendment No.     )

    ​

    Filed by the Registrant  ☐

    ​

    Filed by a Party other than the Registrant  ☐

    ​

    Check the appropriate box:

    ☐Preliminary Proxy Statement

    ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐Definitive Proxy Statement

    ☒Definitive Additional Materials

    ☐Soliciting Material under §240.14a-12

    ​

    INGEVITY CORPORATION


    (Name of Registrant as Specified in Its Charter)

    ​

    ​


    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    ​

    Payment of Filing Fee (Check the appropriate box):

    ☒

    No fee required.

    ☐

    Fee paid previously with preliminary materials.

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

    ​

    .


    GRAPHIC

    Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V85511-P45803 You invested in INGEVITY CORPORATION and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on April 29, 2026. Vote Virtually at the Meeting* April 29, 2026 9:30 AM Eastern Time Virtually at: www.virtualshareholdermeeting.com/NGVT2026 Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting the materials prior to April 8, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. INGEVITY CORPORATION SHAREOWNER SERVICES P.O. BOX 64945 ST. PAUL, MN 55164-0945 INGEVITY CORPORATION 2026 Annual Meeting Vote by April 28, 2026 11:59 PM ET *Ingevity Corporation will be hosting the meeting live via audio webcast this year at the website address above. Please check the proxy materials for instructions on how to virtually attend the 2026 Annual Meeting.

    GRAPHIC

    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V85512-P45803 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the 2026 Annual Meeting, which are further described in the proxy materials that are available to you on the Internet. You may view the proxy materials at http://www.ProxyVote.com or easily request a paper copy. We encourage you to access and review all of the important information contained in the proxy materials before voting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of the below Director nominees, each for a one-year term and until his or her successor is duly elected and qualified: Nominees: 1a. Luis Fernandez-Moreno For 1b. Diane H. Gulyas For 1c. Bruce D. Hoechner For 1d. David H. Li For 1e. Frederick J. Lynch For 1f. Karen G. Narwold For 1g. F. David Segal For 1h. J. Kevin Willis For 1i. Benjamin G. (Shon) Wright For 2. Advisory vote on compensation of our Named Executive Officers (Say-on-Pay). For 3. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026. For 4. Amendment to increase authorized shares under the Ingevity Corporation 2025 Omnibus Incentive Plan. For NOTE: In their discretion, the proxy holders are authorized to vote upon such other business as may properly come before the Annual Meeting or any adjournment thereof.

    Get the next $NGVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NGVT

    DatePrice TargetRatingAnalyst
    2/26/2025$62.00 → $65.00Market Perform → Outperform
    BMO Capital Markets
    8/7/2024$58.00Market Perform → Market Outperform
    CJS Securities
    4/22/2024$52.00 → $62.00Hold → Buy
    Jefferies
    11/6/2023$49.00Market Outperform → Market Perform
    CJS Securities
    10/3/2023$62.00 → $53.00Buy → Hold
    Loop Capital
    8/7/2023$71.00 → $60.00Outperform → Market Perform
    BMO Capital Markets
    7/27/2023$64.00 → $75.00Hold → Buy
    Loop Capital
    5/5/2023$92.00 → $64.00Buy → Hold
    Loop Capital
    More analyst ratings

    $NGVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Operations Clontz Clarence Reid Jr. was granted 2,343 shares and covered exercise/tax liability with 726 shares, increasing direct ownership by 22% to 8,980 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    3/3/26 9:04:44 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SVP, Finance & CAO Platt Phillip John was granted 2,108 shares and covered exercise/tax liability with 1,070 shares, increasing direct ownership by 4% to 29,949 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    3/3/26 9:01:18 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SVP, Gen. Counsel & Secretary Fisher Ryan C. was granted 4,442 shares and covered exercise/tax liability with 1,333 shares, increasing direct ownership by 20% to 18,502 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    3/3/26 8:58:22 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    SEC Filings

    View All

    SEC Form DEFA14A filed by Ingevity Corporation

    DEFA14A - Ingevity Corp (0001653477) (Filer)

    3/17/26 4:26:43 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form DEF 14A filed by Ingevity Corporation

    DEF 14A - Ingevity Corp (0001653477) (Filer)

    3/17/26 4:25:30 PM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form 10-K filed by Ingevity Corporation

    10-K - Ingevity Corp (0001653477) (Filer)

    2/26/26 4:23:25 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ingevity upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously

    2/26/25 7:15:06 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by CJS Securities with a new price target

    CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00

    8/7/24 9:18:13 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by Jefferies with a new price target

    Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously

    4/22/24 7:39:26 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ingevity reports full year and fourth quarter 2025 financial results

    Highlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders Completed sale of North Charleston crude tall oil refinery assets and the majority of Performance Chemicals Industrial Specialties product line Concluded portfolio review and initiated the exploration of strategic alternatives for Advanced Polymer Technologies segment and the Performance Chemicals Road Markings product line Full Year: Total net sales of $1.3 billion, from continuing and discontinued operations, decreased 8% from prior year; net sales from continuing operations of $1.2 billion, down 3% versus prior

    2/25/26 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Gabelli Hosts 17th Annual Specialty Chemicals Symposium

    GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing. Attendees will also have the opportunity to participate in one-on-one meetings with management teams, available upon request. For those who cannot attend in person, access to the symposium will be available via webcast. Investors should contact their Gabelli relations

    2/24/26 8:00:00 AM ET
    $ARQ
    $ASH
    $CC
    Major Chemicals
    Industrials
    Specialty Chemicals
    Consumer Discretionary

    Ingevity announces upcoming board transitions

    Founding directors Daniel F. Sansone and Jean S. Blackwell to conclude board service at the 2026 Annual Meeting Ingevity Corporation (NYSE:NGVT) today announced that two long-serving directors, Daniel F. Sansone and Jean S. Blackwell, will not stand for re-election at the company's 2026 Annual Meeting of Stockholders. Sansone, a founding director since Ingevity became a public company in 2016, is ending his service at the annual meeting in accordance with the board's mandatory retirement age policy. Blackwell, also a founding director, will conclude her tenure at the annual meeting following ten years of service. She previously served as chair of the board and provided essential leaders

    2/23/26 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/12/24 3:54:24 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/4/24 11:52:25 AM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Ingevity Corporation (Amendment)

    SC 13D/A - Ingevity Corp (0001653477) (Subject)

    2/28/24 5:30:32 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Leadership Updates

    Live Leadership Updates

    View All

    Ingevity announces key leadership transitions

    Ingevity Corporation (NYSE:NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future. Chief financial officer transition Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity's financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expan

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity names Ruth Castillo as senior vice president and president of Performance Materials

    Veteran industry leader joins Ingevity to accelerate innovation and strategic growth across company's high performance activated carbon portfolio Ingevity Corporation (NYSE:NGVT) today announced that, effective November 10, 2025, Ruth Castillo has been appointed as president of Performance Materials, the company's unique activated carbon segment which has a long track record of consistent strong financial performance. She will also join Ingevity's executive leadership team as senior vice president. Castillo most recently served as vice president of global chemicals at Avantor. She brings more than 25 years of global experience in the chemicals and materials industries, with proven abili

    10/23/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces departure of Performance Materials segment president, Ed Woodcock

    Ingevity Corporation (NYSE:NGVT) today announced Ed Woodcock, executive vice president and president, Performance Materials, departed the company effective July 1, 2025. Woodcock's departure follows a 37-year career with the company. "Ed Woodcock's leadership has been foundational to the successful growth of Ingevity's Performance Materials activated carbon business as the industry leader in automotive emissions capture," said Ingevity president and CEO, Dave Li. "During his extensive career with the company, Ed drove global expansion of the business, delivered consistently strong profitability and positioned the Performance Materials segment for growth in the hybrid and electric vehicle

    7/1/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Financials

    Live finance-specific insights

    View All

    Ingevity reports full year and fourth quarter 2025 financial results

    Highlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders Completed sale of North Charleston crude tall oil refinery assets and the majority of Performance Chemicals Industrial Specialties product line Concluded portfolio review and initiated the exploration of strategic alternatives for Advanced Polymer Technologies segment and the Performance Chemicals Road Markings product line Full Year: Total net sales of $1.3 billion, from continuing and discontinued operations, decreased 8% from prior year; net sales from continuing operations of $1.2 billion, down 3% versus prior

    2/25/26 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces dates for fourth quarter and full year 2025 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026. The company will host a live webcast on Thursday, February 26, at 10:00 a.m. (Eastern) to discuss fourth quarter and full year 2025 fiscal results. The webcast can be accessed via the investors section of Ingevity's website. Participants may pre-register for the event here. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 102386. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recordin

    2/11/26 9:15:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces results of portfolio review, including plans to explore strategic alternatives for Advanced Polymer Technologies segment and Road Markings business

    Potential divestitures would further enhance portfolio to focus on core businesses which carry best-in-class margins and cash flow generation Ingevity Corporation (NYSE:NGVT) today announced it has completed the company's previously disclosed portfolio review process and is in the early stages of exploring strategic alternatives for its Advanced Polymer Technologies (APT) segment and Performance Chemicals Road Markings business, including a potential sale of one or both. "Ingevity's leadership team and Board remain focused on unlocking long-term value for shareholders," said Dave Li, president and CEO of Ingevity. "Having conducted a thorough review of the Ingevity portfolio, we have dete

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials